Detalhe da pesquisa
1.
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer.
Cell
; 185(11): 1974-1985.e12, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35512704
2.
An update on the immune landscape in lung and head and neck cancers.
CA Cancer J Clin
; 70(6): 505-517, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841388
3.
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
N Engl J Med
; 389(22): 2063-2075, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861218
4.
The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer.
Mol Cell
; 69(1): 87-99.e7, 2018 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29249655
5.
Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.
Oncologist
; 28(12): 1055-1063, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37418599
6.
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
N Engl J Med
; 383(9): 825-835, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846061
7.
Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas.
Future Oncol
; 18(24): 2639-2649, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35815644
8.
Physician Communication and Patient Understanding of Molecular Testing Terminology.
Oncologist
; 26(11): 934-940, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34369626
9.
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 379(4): 341-351, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29863979
10.
Benefits and limitations of real-world evidence: lessons from EGFR mutation-positive non-small-cell lung cancer.
Future Oncol
; 17(8): 965-977, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33242257
11.
ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib.
Cancer
; 126(6): 1339-1350, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31821539
12.
MEK or ERK inhibition effectively abrogates emergence of acquired osimertinib resistance in the treatment of epidermal growth factor receptor-mutant lung cancers.
Cancer
; 126(16): 3788-3799, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32497272
13.
Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589).
Cancer
; 126(9): 2024-2033, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999837
14.
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.
Cancer
; 126(13): 3140-3150, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315457
15.
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.
Cancer
; 126(3): 575-582, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648379
16.
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.
Br J Cancer
; 123(8): 1228-1234, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32704173
17.
Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic Cancer.
Oncologist
; 25(10): e1586-e1588, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744382
18.
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
Oncologist
; 25(3): e528-e535, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162807
19.
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.
Proc Natl Acad Sci U S A
; 114(19): 4993-4998, 2017 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28446615
20.
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
Cancer
; 125(1): 127-134, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30329148